High doses of methylene blue/light treatment crosslink the A-alpha- subunit of fibrinogen: Influence of this photooxidization on fibrinogen binding to platelets

Haemostasis

Volumn 28, Issue 1, 1998, Pages 17-24

  Lorenz, M ^a,b,d   Muller M ^a   Jablonka, B ^c   Vigh, T ^b   Kirchmaier, C M ^d  

^a Institute for Transfusion Medicine and Immunohematology   (Germany)

^b GOETHE UNIVERSITY   (Germany)

^c SANOFI   (France)

^d DEUTSCHE KLINIK FÜR DIAGNOSTIK   (Germany)

Author keywords

Fibrinogen; GPIIb IIIa binding; Methylene blue; Photodynamic virus inactivation

Indexed keywords

FIBRINOGEN; FIBRINOGEN RECEPTOR; METHYLENE BLUE;

ARTICLE; BINDING AFFINITY; BLOOD BANK; BLOOD DONOR; BLOOD TRANSFUSION; CROSS LINKING; HUMAN; HUMAN CELL; NONHUMAN; PHOTOOXIDATION; POLYACRYLAMIDE GEL ELECTROPHORESIS; PRIORITY JOURNAL; THROMBOCYTE AGGREGATION; VIRUS INACTIVATION;

EID: 0032419936     PISSN: 03010147     EISSN: None     Source Type: Journal    
DOI: 10.1159/000022379     Document Type: Article

References (22)

1. Wallis C, Melnick JL: Irreversible photosensitization of viruses. Virology 1964;23:520-527.
2. Wallis C, Melnick JL: Photodynamic inactivation of animal viruses: A review. Photochem Photobiol 1965;4:159-170.
3. Kelly JM, vd Putten WJM, McConnell DJ: Laser flash spectroscopy of methylene blue with nucleic acids. Photochem Photobiol 1987;45:167-175.
4. Schneider JE, Price S, Maidt L, Gutteridge JMC, Floyd RA: Methylene blue plus light mediates 8-hydroxy 2′-dcoxyguanosine formation in DNA preferentially over strand breakage. Nucleic Acids Res 1989;18:631-635.
5. Lambrecht B, Mohr H, Knüver-Hopf J, Schmitt H: Photoinactivation of viruses in human fresh plasma by phenothiazine dyes in combination with visible light. Vox Sang 1991;60:207-213.
6. Yoshimoto T, Saito Y, Inada Y: Non-clottable fibrinogen by photooxidation in blood plasma. Photochem Photobiol 1987;5:675-676.
7. Mohr H, Pohl U, Lambrecht B, Wieding JU, Schmitt H: Durch Methylenblau/Licht-Behandlung virus-inaktiviertes Humanplasma: Herstellung und bisherige klinische Erfahrung. Infusionther Transfusionsmed 1993;20(suppl 2):19-24.
8. Hantgan RR, Charles W, Marder F, Marder VJ: Fibrinogen structure and physiology; in Colman RW, Hirsh J, Marder VJ, Salzmann JB (eds): Hemostasis and Thrombosis. Basic Principles and Clinical Practice. Philadelphia, Lippincott, 1994, pp 277-293.
9. Bradford M: A rapid and sensitive method for the quantitation of microgram quantities of protein utilizing the principle of protein-dye binding. Anal Biochem 1976;72:248-254.
10. Jacobson E, Kierulf P: A modified beta-alanine precipitation procedure to prepare fibrinogen free of antithrombin III and plasminogen. Thromb Res 19973;3:145-159.
11. 4. Nature 1970;227:680-685.
12. Marguerie GA, Plow EF, Edgington TS: Human platelets possess an inducible and saturable receptor specific for fibrinogen. J Biol Chem 1979;254:5357-5363.
13. Marguerie GA, Edgington TS, Plow EF: Interaction of fibrinogen with its platelet receptor as part of a multistep reaction in ADP-induced platelet aggregation. J Biol Chem 1980;255:154-161.
14. Kornecki E, Niewiarowski S, Morinello TA, Kloczewiak M: Effects of chymotrypsin and adenosine diphosphate on the exposure of fibrinogen receptors on normal human and Glanzmann's thrombasthenic platelets. J Biol Chem 1981;256:5696-5701.
15. Bennet JS, Vilaire G: Exposure of platelet fibrinogen receptors by ADP and epinephrine. J Clin Invest 1979;64:1393-1401.
16. Pytela R, Picrschbacher MD, Ginsberg MH, Plow EF, Ruoslathi E: Platelet membrane glycoprotein IIb/IIIa: Member of a family of Arg-Gly-Asp-specific adhesion receptors. Science 1986;231:1559-1562.
17. Parise LV, Phillips DR: Reconstitution of the purified platelet fibrinogen receptor: Fibrinogen binding properties of the glycoprotein IIb-IIIa complex. J Biol Chem 1991;260:10698-10707.
18. Charo IF, Nannizzi L, Phillips DR, Hsu MA, Scaarborough RM: Inhibition of fibrinogen binding to GP IIb-IIIa by a GP IIIa peptide. J Biol Chem 1991;266:1415-1421.
19. 3 and glycoprotein IIb-IIIa with fibrinogen: Differential peptide recognition accounts for distinct binding sites. J Biol Chem 1990;265:12267-12271.
20. Cheng Y, Prusoff WH: Relationship between the inhibition constant and the concentration which causes 50 percent inhibition of an enzymatic reaction. Biochem Pharmacol 1973;22:3099-3108.
21. Giorotti AW: Protoporphyrin-induced photodynamic effects on band 3 protein of human erythrocyte membranes. Biochim Biophys Acta 1980;602:45-56.
22. Bachmann B, Knüver-Hopf J, Lambrecht B, Mohr H: Target structures for HIV-I inactivation by methylene blue and light. J Med Virol 1995;47:172-178.